H.C. Wainwright Initiates Coverage on Acrivon Therapeutics (ACRV) With “Buy” Rating and $19 PT
H.C. Wainwright Initiates Coverage on Acrivon Therapeutics (ACRV) With “Buy” Rating and $19 PT Faheem Tahir Sat, November 29, 2025 at 2:26 PM GMT+8 2 min read In this article: ACRV 0.00% With strong t...